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Abstract
Background: Tuberous sclerosis complex (TSC) is a multisystem disorder that results from mutations in the TSC1 or
TSC2 genes, leading to constitutive activation of the mammalian target of rapamycin (mTOR) signaling pathway.
Cortical tubers represent typical lesions of the central nervous system (CNS) in TSC. The pattern of cortical layering
disruption observed in brain tissue of TSC patients is not yet fully understood, and little is known about the origin
and phenotype of individual abnormal cell types recognized in tubers.
Methods: In the present study, we aimed to characterize dysmorphic neurons (DNs) and giant cells (GCs) of cortical
tubers using neocortical layer-specific markers (NeuN, SMI32, Tbr1, Satb2, Cux2, ER81, and RORβ) and to compare the
features with the histo-morphologically similar focal cortical dysplasia (FCD) type IIb. We studied a cohort of nine
surgically resected cortical tubers, five FCD type IIb, and four control samples using immunohistochemistry and in situ
hybridization.
Results: Cortical tuber displayed a prominent cell loss in all cortical layers. Moreover, we observed altered proportions
of layer-specific markers within the dysplastic region. DNs, in both tubers and FCD type IIb, were found positive for
different cortical layer markers, regardless of their laminar location, and their immunophenotype resembles that of
cortical projection neurons.
Conclusions: These findings demonstrate that, similar to FCD type IIb, cortical layering is markedly disturbed in cortical
tubers of TSC patients. Distribution of these disturbances is comparable in all tubers and suggests a dysmaturation
affecting early and late migratory patterns, with a more severe impairment of the late stage of maturation.
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Background
Tuberous sclerosis complex (TSC) is a genetic disease
caused by mutations in the TSC1 and TSC2 genes. The
two proteins encoded by these genes—tuberin and
hamartin—are key regulators of the mammalian target
of rapamycin complex 1 (mTORC1) [1]. Therefore, the
disease affects multiple organ systems already during de-
velopment. Brain lesions can be found in about 90 % of
patients with TSC and are often associated with intract-
able epilepsy [2–4]. Only about 40–60 % of all patients
with TSC and epilepsy become seizure-free on medica-
tion. In a selected subset of TSC patients, epilepsy sur-
gery is considered as a therapeutic option after careful
presurgical evaluation [5].
Histology of resected cortical tubers reveals a severely
distorted cortex with apparent loss of cortical layers and
presence of abnormal cell types (reviewed in [3, 6]). The
most common aberrant cell types are dysmorphic neu-
rons (DNs) and bright eosinophilic giant cells (GCs);
these are very large cells lying scattered within the cor-
tex and condensed in the white matter. The increase in
cellular mass can be explained by the over-activation of
anabolic metabolism [7]. Accordingly, the underlying
genetic defect results in a constitutive activation of
mTORC1 with consequent increase in protein synthesis
caused by the production of additional ribosomes and
increased rates of messenger RNA translation [8]. The
increased knowledge concerning the molecular basis of
GC formation has led to novel therapeutic strategies in
patients with TSC [9].
However, the origin and phenotype of abnormal cells
observed in cortical tubers remain still unclear. It was
speculated that in focal cortical dysplasia type IIb (FCD
type IIb; [10])—a pathology similar to cortical tubers—
these cells arise from radial glial progenitor cells of the
ventricular zone representing different stages of matur-
ation [11].
Recently, the recognition of layer-specific neuronal cell
markers of the neocortex allowed detailed studies about
cortical layer formation. These studies provided insight
into the origin and phenotype of cortical neurons in nor-
mal cortex but may also contribute to define the pattern
of cortical layer disruption in different malformations of
cortical development (MCD) in the human brain. These
markers specifically labeled subsets of cortical neurons
with limited laminar distribution [12]. Furthermore,
there is evidence that the identity of each neuron within
the neocortex (type of neuron or laminar fate) is prede-
termined even before the onset of migration [13]. Sev-
eral studies have been published studying cortical layer
markers in FCD. Previous results suggested that FCD
samples contain more immature cells than age-matched
controls, indicating an activation of progenitor cells that
might contribute to the pathophysiology of these lesions
[14]. In FCD type IIb, DNs and balloon cells (BC; similar
to GCs in cortical tuber) showed distinct expression of
layer markers supporting an origin from radial glia and
intermediate progenitor cells [14]. Differences in neur-
onal maturation between FCD subtypes, as well as the
existent laminar structure in normal-appearing neurons,
led to the conclusion that only a subpopulation of pre-
cursor cells is affected [15]. However, another study sug-
gested that these differences might reflect a differential
expression of cortical layer markers in various brain re-
gions [16].
In the present study, we aimed to investigate the expres-
sion of a panel of layer-specific markers covering all cor-
tical layers (Satb2, Cux2, RORβ, ER81, Tbr1, SMI32, and
NeuN) in cortical tubers of patients with TSC compared
to perilesional cortex of the same patients, as well as to
FCD type IIb or aged- and location-matched controls.
Methods
Subjects
In total, we collected nine cortical tubers and five FCD
type IIb samples from various epilepsy surgery centers
(Department of Pediatric Neurology, Brain Center
Rudolf Magnus, University Medical Center Utrecht; De-
partment of Pediatric Neurology, Charles University, 2nd
Faculty of Medicine, Motol University Hospital, Prague;
Evangelisches Krankenhaus Mara Bethel-Bielefeld, Biele-
feld, Germany; Department of Neuropathology, University
Hospital Erlangen, Erlangen, Germany) for this study. Ex-
tensive presurgical evaluation including 24 h to 5 days
video-EEG monitoring, high-resolution MRI, and neuro-
psychological testing was performed in each patient in
order to identify the epileptogenic zone (EZ) before tai-
lored surgical resection. Perilesional cortex (if available in
both pathologies) was also included as defined by the lack
of dysmorphic neurons and giant/balloon cells in the
cortex.
We included an age-matched autopsy control group
(n = 4). None of these patients had a history of seizures
or other neurological diseases.
Tissue was obtained and used in accordance with the
Declaration of Helsinki and the AMC Research Code
provided by the Medical Ethics Committee and ap-
proved by the science committee of the UMC Utrecht
Biobank. The local ethical committees of all participating
centers gave permission to undertake the study.
Tissue preparation and immunohistochemistry
The tissue was carefully oriented, cut perpendicular
to the pial surface, fixed overnight in 4 % formalde-
hyde, and routinely processed into liquid paraffin.
Sections were cut at 4–6 μm with a microtome (Microm,
Heidelberg, Germany) and mounted on positively charged
slides (Superfrost +Menzel, Germany). Each specimen
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was histopathologically examined using hematoxylin and
eosin (H & E). In autopsy controls, an additional Nissl
staining was performed to calculate overall neuronal
densities.
An immunohistochemical examination of all surgical
specimens was performed using the following panel of
antibodies: NeuN (neuronal nuclei, 1:100, clone A60,
Chemicon, Temecula, CA, USA), non-phosphorylated
neurofilament H (1:1000, clone SMI32, Sternberger,
Lutherville), Satb2 (1:400, clone SATBA4B10, Abcam,
Cambridge, UK), and Tbr1 (1:50, polyclonal rabbit,
Abcam, Cambridge, UK).
The slides were air-dried overnight at 37 °C. All im-
munohistochemical stainings were performed with a
Ventana semi-automated staining machine (Benchmark
ULTRA; Ventana, Illkirch, France) and the Ventana
DAB staining system according to the manufacturer’s
protocol.
In situ hybridization
In situ hybridization (ISH) for Cux2, RORβ, and ER81
were performed using a 5′–3′ double digoxygenin
(DIG)-labeled superior probes (containing locked nucleic
acid [LNA] and 2′O-Methyl [2’OMe] RNA moieties; “l”








The hybridizations were done on 5-μm sections of
paraffin-embedded materials as described previously
[17, 18]. The probes were hybridized at 62 °C for 1 h, and
the hybridization was detected with alkaline phosphatase
(AP)-labeled anti-DIG (Roche Applied Science, Basel,
Switzerland). NBT (nitro-blue tetrazolium chloride)/BCIP
(5-bromo-4-chloro-3’-indolyphosphate p-toluidine salt)
was used as chromogenic substrate for AP. Negative con-
trol assays were performed without probes and without
primary antibody (sections were blank).
Quantitative analysis of the immunopositive cells and the
ISH signals
To study the alteration of cortical layering, the cortex
was divided into three regions: supragranular layers (L1-
3, SG), layer 4 plus infragranular layers (L4-6, IG), and
deep white matter (>500 μm WM). The number of
immunopositive cells was counted at ×10 magnification
in five representative fields of L1-3 and L4-6 as well as
10 visual fields of WM. If applicable, the tuber samples
were divided into perilesional cortex (PLx) and full-
blown tuber (Tb). Perilesional was considered if the cor-
tex showed a normal cortical architecture and no signs
of DNs or GCs. A variable degree of giant cells in the
white matter was always present.
Statistical analysis
Statistical analysis was performed on SPSS 21 (IBM,
PASW Statistics, USA). The total number of positive
cells as well as the ratio of positive cells divided by the
total amount of neurons was used for computing the
analysis. Descriptive statistics (median, range) and non-
parametric testing were performed to evaluate between-
group differences. p < 0.05 was considered significant.
Results
Demographic patient data
Our cohort of epilepsy surgery patients consisted of six
female and eight male patients. The control group con-
sisted of two females and two males. Cortical tubers
were resected temporally in five cases and frontally in
four cases. The somatic mutation in the TSC gene was
known in three of the patients (TSC1 = 1; TSC2 = 2).
The site of FCD type IIb was frontal in four cases and
occipital in one. The control group comprised two
frontal, one temporal, and one occipital sample. The me-
dian age at surgery was 5.00 years (range = 3.00–36.00)
in patients with TSC, 12.00 years (range = 1.00–36.00) in
patients with FCD type IIb, and 8.50 years (range =
07.00–12.00) in controls.
The first step of the analysis included a general assess-
ment of cortical layering in our different cohorts.
Cortical layer disruption in TSC cortical tubers and FCD
type IIb
In order to determine the extent of dyslamination in TSC
cortical tubers, we first addressed the total number of
neurons in cortical layers as well as in the white matter
from cortical tubers and FCD type IIb (Fig. 1a–i). In our
cohort, we detected a significant neuronal cell loss in cor-
tical tubers and FCD type IIb when compared to perile-
sional tissue and non-epileptic autopsy specimens
(Kruskal-Wallis, p = 0.000, Table 1, Fig. 1j). In addition,
there was a significant increase in heterotopically placed
neurons in deep white matter in both pathologies com-
pared to our control samples (Kruskal-Wallis, p = 0.033,
Table 1, Fig. 1k, Additional file 1: Figure S1). As previously
reported [19], DNs are characterized by a pathologic accu-
mulation of non-phosphorylated neurofilament (SMI32)
in both FCD type IIb and cortical tubers, and we observed
significantly more DNs present in the neocortex of FCD
type IIb than cortical tubers (Kruskal-Wallis, p = 0.017,
Table 1, Fig. 1l, Additional file 1: Figure S1).
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Next, we looked at neuronal fate determination in the
remaining neuronal populations utilizing layer-specific
markers.
Satb2 and Cux2 expression
Neurons in the upper cortical layers were defined by their
immunoreactivity for Satb2+ (known to be expressed in L2,
L3, L4, and L5; Fig. 2a–h) and Cux2 (normally expressed in
L2 und L3, Fig. 2i–p) [12, 14–16, 20, 21]. Overall, the amount
of Satb2+ neurons was decreased in perilesional cortex, cor-
tical tubers, and FCD type IIb compared to non-epileptic aut-
opsy controls (Kruskal-Wallis, p= 0.003, Table 1, Fig. 2q,
Additional file 1: Figure S1). The proportions of neurons that
were Satb2+ and subsequently corrected for the total amount
of neurons showed a trend towards loss of Satb2+ neurons in
lower cortical layers in TSC tissue (perilesional and tuberal;
L5) compared to controls and FCD type IIb (Table 1, Fig. 2r,
Additional file 1: Figure S1). However, statistical testing failed
to reach significance (Kruskal-Wallis, p = 0.083). DNs
throughout all cortical layers were Satb2+ in eight cortical
tubers and two FCD type IIb samples (Table 2). Except for
one sample of FCD type IIb, all giant/balloon cells (GCs/
BCs) of layer 1 and in the white matter were strongly posi-
tive for Satb2 (Table 2, Fig. 2f–h).
Cux2 expression was according to previously pub-
lished data considered normal in control and perilesional
Fig. 1 Cortical disorganization in TSC cortical tubers. a Normal control cortex with classic 6-layered lamination. b, c Normally shaped neuronal
cells of supra- and infragranular layers. d Deep white matter in a control patient. e Normal appearing cortex in a perilesional sample. f Cortical
dyslamination of FCD type IIb in a patient with difficult-to-treat frontal lobe epilepsy. g Dysorganization of the cortex in a cortical tuber of a
patient with genetically proven TSC. h, i Dysmorphic neurons (arrows) are present throughout the whole cortex. Scale bar in g equals 500 μm
and applies also to a, e, and f. Scale bar in i equals 200 μm and applies also to b–d. j Loss of neurons throughout all cortical layers in TSC cortical
tubers and FCD type IIb. k Significant increase in heterotopic neurons in the deep white matter in patients who underwent surgery for FCD Type
IIb or cortical tuber resection. l A larger amount of dysmorphic neurons can be detected in FCD type IIb compared to TSC cortical tubers. SG
supragranular layers, IG infragranular layers, WM white matter, Co control, PLx perilesional cortex, Tb cortical tuber, IIb FCD type IIb
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cortex when showing strong expression in L2 and L3
(Fig. 2i–l) [21–23]. In contrast to normal Cux2 distribu-
tion, only in upper layers L2 and L3 in controls, cortical
tubers showed less Cux2+ cells in the upper layers
(Kruskal-Wallis, p = 0.023). Corrected for neuronal num-
ber, there was however no difference. DNs were strongly
Cux2+ throughout all layers of cortical tubers. Nonethe-
less, in four out of nine cases, all normally appearing
neurons also expressed Cux2 (Fig. 2m–p). Expression
was never detected in giant cells. In FCD type IIb, we
observed a similar pattern, although the expression pat-
tern was limited to the upper cortical layers in one case.
RORβ expression
Neurons of the internal granular layer (L4) can be
assessed by ascertaining the expression pattern of RORβ.
In our control samples and perilesional cortex, expres-
sion of RORβ was restricted to L4 with some scattered
neurons in L6 (Fig. 3a–d). We observed reduced expres-
sion of RORβ in the lower layers of cortical tubers and
FCD type IIb cases (Kruskal-Wallis, p = 0.024). However,
strong expression was found in DNs of all cortical layers
whereas only in two cases of TSC and in one case of
FCD type IIb GCs/BCs were slightly stained on ISH
(Table 2). Some of the remaining normal-appearing neu-
rons showed also expression in L4-L6 (Fig. 3e–h).
Tbr1 and ER81 expression
The lower cortical layers (L5/6) can be determined via
the expression of Tbr1 and ER81. In general, we ob-
served a decrease in the total numbers of Tbr1+ neurons
in cortical tubers and FCD type IIb samples (Fig. 4a–d).
However, we detected an overall increase in Tbr1+ neu-
rons in the perilesional cortex (TSC and FCD IIb;
Kruskal-Wallis, p = 0.000; Fig. 4e–i) which failed to reach
significance if corrected for the number of neurons. None-
theless, there was a tendency towards increased number
of neurons in the upper cortical layers of cortical tubers
and FCD type IIb (Fig. 4j, Addtional file 1: Figure S1); this
failed to show significance. DNs and GCs/BCs were nega-
tive. The number of cells positive for Tbr1 in the white
matter of both pathologies also showed a trend towards
increase (Kurskal-Wallis, p = 0.089; Table 2).
Lastly, we focused on the expression pattern of ER81.
In autopsy controls and perilesional cortex, the expres-
sion of ER81 was restricted to L5/6 (Fig. 5a/b). This
pattern was also found in cortical tubers (Fig. 5d). None-
theless, in FCD type IIb, we detected a tendency towards
the increase of normal-appearing neurons that expressed
ER81 in the upper cortical layers (Kruskal-Wallis, p =
0.069, Fig. 5c). DNs in cortical tubers and FCD type IIb
showed a strong expression of ER81. GCs were slightly
stained in three cases. BCs were negative (Table 2).
Normal-appearing neurons in the white matter were
positive for ER81.
For all markers, there was no difference between peri-
lesional cortex of cortical tubers and FCD type IIb.
Discussion
The development of the human cerebral cortex depends
on a precisely orchestrated cascade of events, including
proliferation, migration, differentiation, and maturation
of neural progenitor cells [24]. The mTOR pathway
plays important roles during cortical development, being
involved in the regulation of cell growth, proliferation,
and survival. Thus, a deregulation of this pathway during
corticogenesis can dramatically hamper cortical lamin-
ation [25, 26]. Accordingly, aberrant activation of this
signaling pathway cascade has been identified in a
large spectrum of MCD, TSC being the prototype of
this category of MCD which have been referred to as
“mTORopathies” [27].
Studying cortical layer formation in malformations of
cortical development has recently become possible by
the use of neocortical layer-specific markers [12]. The
present study provides insights in the pattern of cortical
layering in TSC cortical tubers. In summary, we observed
(See figure on previous page.)
Fig. 2 Composition of the upper cortical layers. a–d Satb2-positive neurons are predominantly in the upper layers of the neocortex. e Loss of
Satb2+ cells throughout all layers in TSC cortical tubers. f–h Expression of Satb2 in dysmorphic neurons (arrows in f and g) and giant cells (arrows
in h) of cortical tubers. i–l Normal distribution of Cux2 expressing cells in the control cortex. m Cux2+ cells throughout all layers in TSC cortical
tubers. n–p Expression of Cux2 in dysmorphic neurons (arrows in n and o) and giant cells (arrows in p) of cortical tubers. Scale bar in m equals
500 μm and applies also to a, e, and I. Scale bar in p equals 200 μm and applies also to b–d, f–h, j–l, and n–l. q Quantitative analysis of Satb2+
neurons revealed significant overall cell loss in all epilepsy surgery specimens. r Relative loss of Satb2+ neurons in TSC tissue. SG supragranular
layers, IG infragranular layers, WM white matter, Co control, PLx perilesional cortex, Tb cortical tuber, IIb FCD type IIb
Table 2 Expression pattern of cortical layer markers in aberrant
cell forms
TSC cortical tubers FCD type IIb
DN GC DN BC
Satb2 20 % 80 % 15 % 80 %
Cux2 80 % 0 % 80 % 0 %
RORβ 80 % 10 % 80 % 5 %
Tbr1 0 % 0 % 0 % 0 %
ER81 80 % 15 % 80 % 0 %
Only minor differences between TSC cortical tubers and FCD type IIb cells
TSC tuberous sclerosis complex, FCD focal cortical dysplasia, DN dysmorphic
neurons, GC giant cells, BC balloon cells
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an overall loss of neurons in all cortical layers. We ob-
served further a proportional loss of Satb2+ neurons in
lower cortical layers. In contrast, Cux2 was expressed in
all cortical layers of tubers and FCD type IIb. In addition,
we detected an increase of Tbr1+ and ER81 expressing
cells in upper cortical layers. The distinct patterns of dis-
ruption of upper and lower cortical layers indicate that
dysmaturation of the cortex is a key feature also in TSC
brain. However, our data suggests that the upper cortical
layers are more severely hampered due to the remnants of
neurons that were supposed to relocate in deeper cortical
layers implying a more serious impairment of their late
stage of maturation.
Satb2, Cux2, RORβ Tbr1, and ER81 expression patterns in
TSC: loss of projection neurons in cortical tubers
Satb2 is an AT-rich DNA-binding protein that has been
shown to represent a postmitotic determinant for upper-
layer neuron specification in the neocortex [28, 29]. Pre-
vious studies reported that Satb2+ cells are present in
the layers 2 and 3. Additionally, it was suggested that
they disappear after 3 months of age in the human brain
[20, 29]. On the contrary, it was also reported that
Satb2+ cells remain as a subpopulation in the upper
cortical layers of the human brain but also extending
towards layer 5 (having a predisposition for the frontal
lobe) [30, 31]. In our study, expression of Satb2 was
detected in L2, 3, and 5 in both perilesional samples and
postmortem controls. In TSC cases (tuber and peritubetal
cortex), we observed a lower number of Satb2+ neurons
compared to controls and there was a tendency towards a
loss of Satb2+ neurons in L5 compared to both controls
and FCD type IIb. These findings are therefore suggestive
for a specific loss of cells in a subpopulation of cortical
neurons in TSC indicating an abnormal formation of pyr-
amidal cells. However, abnormal Satb2 expression in the
superficial region of the neocortex has been previously re-
ported in FCD type II, showing a different pattern com-
pared to hemimegalencephaly, which is characterized by a
diffused Satb2 cortical expression pattern [20]. Altered
Satb2 expression patterns by random migration were also
reported in various lissencephalies [29]. Another study fo-
cusing on FCD showed Satb2+ neurons diffusely distrib-
uted in the cortex and/or the white matter of FCD type II
cases, without differences in Satb2+ cell densities between
FCD type IIa and FCD type IIb [15]. In addition, we ob-
served Satb2 expression in both DNs and GCs/BCs. How-
ever, previous studies evaluating Satb2 expression in FCD
case do not specify the cell subtypes (DNs, BCs, normal-
appearing neurons); thus, comparison cannot be performed.
Cux proteins, putative markers of upper cortical layer
neurons [22], have been shown to be critically involved
in the regulation of normal dendritic development of
L2-3 neurons [23]. In agreement with previous studies
Fig. 3 Neurons of L4. a–d Regular expression pattern of RORβ in normal control cortex. e–h Widespread RORβ expression throughout the whole
cortex in TSC cortical tubers with positivity in DNs (arrows f, g) in and some GCs (arrows in h). Scale bar in e equals 500 μm and applies also to
a and e. Scale bar in h equals 200 μm and applies also to b, c, d, f, and g. SG supragranular layers, IG infragranular layers, WM white matter, Co
control, Tb cortical tuber
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in human neocortex [21], in both control and TSC-
perituberal cortex, Cux2 mRNA was expressed in L2-3.
However, in cortical tubers, this pattern was disrupted
and the expression of Cux2 was extensively heteroge-
neous with variable expression in normal-looking neu-
rons and DNs (also in FCD IIb), but not in GCs in our
cohort. It seems therefore that the fate determination of
these neurons is altered and they stay diffusely behind
throughout the whole cortex without finding its proper
way towards the upper layers. In addition, expression of
Cux2 mRNA in both abnormal and DNs has been also
reported in a larger cohort of FCD cases, without
Fig. 4 Tbr1+ neurons of the lower cortical layers. a–d Regular distribution of Tbr1+ neurons in control cortex. e–h Decrease in overall Tbr1+
neurons in TSC and FCD type IIb. Scale bar in e equals 500 μm and applies also to a and e. Scale bar in h equals 200 μm and applies also to b, c,
d, f, and g. i Quantitative increase in Tbr1+ neurons in perilesional cortex (PLx). j Quantitative increase of Tbr1+ cells in the upper cortical layers.
SG supragranular layers, IG infragranular layers, WM white matter, Co control, PLx perilesional cortex, Tb cortical tuber, IIb FCD type IIb
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revealing any differences between type IIa and IIb [21].
In contrast, Cux1 protein expression has not been de-
tected in DNs [14].
The RORβ gene is known as a selective marker for
internal granular layer (L 4) of mammalian neocortex
[12, 32, 33]. According to previous studies [16, 21, 33],
also in our cohort of controls and perilesional TSC cortex,
expression of RORβ mRNA was intensely expressed in L4.
In cortical tubers remaining normal-appearing neurons
maintained the expression RORβ in L4. These results are
partly in line with the reported pattern in FCD II cases
[16, 21]. In our cohort, similar pattern was observed in tu-
bers with different cortical localization, whereas differ-
ences between frontal and temporal resections have been
reported in FCD cohorts [16]. RORβ expression was also
detected in DNs, distributed throughout all layers within
the tuber. Expression of RORβ mRNA in DNs has been
also reported in FCD type II [21].
Tbr1 and ER81 are well-known neocortical layer-
specific markers used to identify the lower cortical layers
(L5/6) [16, 34, 35]. Tbr1 gene encodes a transcription
factor necessary for the differentiation of neural stem
cells in developing brain and highly expressed in gluta-
matergic early-born cortical neurons [12, 34, 36, 37]. Ac-
cording to these previous studies, Tbr1 was prominently
expressed in the lower cortical layers. In both TSC and
FCD cases, we observed a lower number of Tbr1+ neu-
rons compared to controls and perilesional cortex; how-
ever, if corrected for the total number of neurons, there
was a tendency towards an increased number of neurons
in the upper cortical layers and in the white matter of epi-
lepsy surgery specimens. Abnormal distribution of Tbr1+
cells throughout the cortex has been reported in both
FCD and hemimegalencephaly [14, 20], and localization of
Tbr1+ cells in the superficial cortical region has been ob-
served in FCD type II cases [20]. In our cohort, we also
observed an increase in Tbr1+ neurons in the perilesional
cortex. Interestingly, increasing evidence indicates the ex-
tension of structural and molecular abnormities in the
perilesional cortex which is an integral part of the epileptic
network in TSC brain [38–41].
The transcription factor ER81 represents another
marker of the projection neurons of L5-6 [12, 42, 43].
ER81 mRNA expression pattern was preserved in the
perilesional cortex. In cortical tubers, the constitutive
expression pattern in normal-appearing neurons was
relatively preserved; however, strong ER81 expression
was detected in DNs throughout the dysplastic cortex.
Expression of Er81 in both DNs and normal-appearing
neurons has been also observed in FCD type II cases
[21, 35]. In agreement with previous reports [16, 35],
ER81 expression was also observed in normal-appearing
neurons in the white matter of all surgical epilepsy spec-
imens and in the upper cortical layer of FCD cases [35].
Nonetheless, these findings should be carefully inter-
preted in the light of an overall reduction of neurons in
cortical tubers and FCD type IIb [44].
How can the altered layer-specific marker expression
be interpreted in the context of the pathogenesis of the
lesions? The data in TSC and FCD type II suggest an
Fig. 5 Expression pattern of ER81. a Strong reactivity for ER81 in the layers 5/6 in normal controls. b No differences in perilesional cortex (PLx).
c Increased amount of ER81 expressing neurons in the upper layers of the neocortex in FCD type IIb (arrows). d Strong reactivity in DNs of
cortical tubers (arrows), however, the constitutive expression pattern in normal appearing-neurons remains intact. Scale bar in d equals 500 μm
and applies also to a–c. SG supragranular layers, IG infragranular layers, Co control, PLx perilesional cortex, Tb cortical tuber; IIb FCD type IIb
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aberrant migration with a greater impairment in late
stage cortical development as a common etiopathogenic
mechanism underlying the pattern of cortical layer dis-
ruption observed in both lesions. The relative layer pres-
ervation reported in other types of FCD (such as FCD
IIIa; [16]) indicates more a lesion-induced cause rather
than simply the effect of seizure activity. The constitu-
tive activation of mTOR (observed in both TSC and
FCD type II) as a consequence of the underlying genetic
defects may represent the common molecular link
resulting in abnormal cell morphology, migration, and
differentiation during corticogenesis and contributing
to the aberrant protein expression observed in these
lesions.
Cortical layer disruption in TSC cortical tubers
Evaluation of the neuronal densities (with a pan-
neuronal maker) in our cohort of TSC patients revealed
significant neuronal cell loss in cortical tubers compared
to both perilesional tissue and non-epileptic autopsy
controls. A similar reduction of neuronal densities is
also detected in FCD type IIb cases. Our findings are in
line with previous stereological studies performed in
FCD cases (including both pediatric and adult cases).
These already showed lower cortical neuronal densities
in the region of dysplasia (particularly in FCD type IIb)
compared to the adjacent cortex or non-epilepsy con-
trols, regardless of age and cortical localization [35, 44].
Whether reduced neuronal densities may simply reflect
Fig. 6 Schematic overview of layer marker expression. a Cortical layer markers are expressed in normal cortex as follows: Cux2: layers II and III
(blue); Satb2: layers II, III, IV, and V (green); RORβ in layer IV and to a lesser extent layer VI (orange); ER81 in layers V and VI (purple), and Tbr1 in
layers V and VI and few white matter neurons (red). b, c Expression pattern of cortical layer markers in tubers and FCD type IIb: dysmorphic
neurons strongly expressed Cux2, RORβ, and ER81 and to a lesser extent Satb2 throughout all layers of the cortex. They did not express Tbr1.
Giant cells of cortical tubers often expressed Satb2, ER81, or none of the markers. Balloon cells of FCD type IIb showed a similar pattern although
to a lesser extent, BCs did more frequently express none of the markers. Trends observed in normal-appearing neurons: Cux2+ and Satb2+ neurons
were less in cortical tubers. The RORβ+ cells of layer IV were reduced in both pathologies. The expression of Tbr1 and ER81 was increased in the upper
cortical layers and was also present in normal-appearing neurons of the white matter. Triangles neurons, circles giant/balloon cells, SG supragranular
layers, IG infragranular layers
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cortical volume, expansion is still a matter of discussion
since archival paraffin blocks are not suitable for accur-
ate evaluation of the total volume of the dysplastic re-
gion [35, 45]. However, in TSC patients (but not in FCD
patients), lower gray matter NeuN densities have been
shown to be correlated with reduced MRI gray and
white matter volumes, suggesting a reduced neuronal
production during corticogenesis (failure of progenitor
cell proliferation) [46]. However, we cannot exclude se-
lective vulnerability of neurons in which the mTOR sig-
naling is activated. Accordingly, hyperactivation of this
pathway has been shown to contribute to cell damage,
promoting aging-related changes (reviewed in [47]. Our
recent observations suggest that the abnormal activation
of mTOR may contribute to apoptosis signaling pathways
and premature activation of mechanisms of neurodegen-
eration in both FCD type II and TSC [48]. Interestingly,
although DNs were detected in all cortical layers in both
FCD type IIb and TSC cortical tubers, their number was
lower in cortical tubers compared to FCD.
We also observed a significant increase in heterotopic
neurons in the deep WM in both FCD and TSC speci-
mens compared to controls. This, however, represents a
common finding in epilepsy cases, including FCD [46, 49],
as well as mild malformation of cortical development
(mMCD) [50]. Moreover, the mechanisms underlying the
presence of heterotopic WM neurons (i.e., local migratory
failure or to incomplete regression of subplate neurons),
their relationship with seizure activity, and their role in
epileptogenesis remain still unclear [50, 51].
Conclusions
In summary, our findings provide insight in the abnor-
mal pattern of lamination observed in cortical tubers
(summarized in Fig. 6). We provide evidence for an ex-
cess of early stage migrational neurons (ER81 and Tbr1)
shifting towards the upper layers and therefore hamper-
ing late stage migration albeit only the subpopulation of
CUX2 expressing cells being affected and leaving the
Satb2 population intact. The existence of hidden cortical
lamination involving normal-looking neurons has also
been recently reported in FCD type II [21]. Moreover,
similar to FCD type II [16, 21, 35], DNs (and to a lesser
extent GCs) in cortical tubers displayed variable expres-
sion of different cortical layer markers (Satb2, Cux2,
RORβ, and Er81) regardless of their laminar location,
supporting their altered migratory pattern. The immu-
nophenotype of DNs in TSC, similar to FCD type II
cases [35], resembles that of cortical projection neurons
and suggests an alteration of a selected population of
intermediate progenitor cells. Several hypotheses con-
cerning the contribution of DNs and BCs/GCs to local
pattern of cortical lamination have been proposed
[52, 53], suggesting that both cell-autonomous and non-
cell-autonomous mechanisms may be operative during
corticogenesis in TSC brain.
Additional file
Additional file 1: Figure S1. A. Loss of neurons throughout all cortical
layers in TSC cortical tubers and FCD type IIb. B. A larger amount of
dysmorphic neurons can be detected in FCD type IIb compared to TSC
cortical tubers. C. Significant increase in heterotopic neurons in the deep
white matter in patients who underwent surgery for FCD Type IIb or
cortical tuber resection. D. Quantitative analysis of Satb2+ neurons
revealed significant overall cell loss in all epilepsy surgery specimens.
E. Relative loss of Satb2+ neurons in TSC tissue. F. Quantitative increase
in Tbr1+ neurons in perilesional cortex (PLx). G. Quantitative increase of
Tbr1+ cells in the upper cortical layers. (TIF 26642 kb)
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